DAB2 and gastric cancer: In addition, by survival analysis of GC patients derived from TCGA dataset, combined survival analyses of DAB2 and AXL, CTGF, or CYR61 in GC patients demonstrated that high DAB2/AXL, DAB2/CTGF, and DAB2/CYR61 levels are associated with worse OS.